Abby Bronson's Blog – August 2017 Archive (2)
FDA Announces Approval of First Gene Therapy in the United States
Yesterday, Kymriah, a gene therapy made by Novartis that treats an aggressive type of leukemia was approved for children and young adults. The new commissioner of the FDA, Dr. Scott Gottlieb, remarked on the FDA's approval of the first gene…
ContinueAdded by Abby Bronson on August 31, 2017 at 1:00pm — No Comments
Webinar Q&A: Gene Therapy for Duchenne
With trials in gene therapy on the horizon, and terms like "cassette", "construct", "promoter", and "transduce" being thrown around, we want to ensure that you, our Duchenne Community, has all the knowledge you need to navigate the world of gene therapy.
Earlier this month, PPMD hosted a webinar with Lee Sweeney, PhD (University…
Added by Abby Bronson on August 23, 2017 at 8:00pm — No Comments
Latest Blog Posts
- Your gift helps PPMD expand gene therapy
- PPMD Research Update: Gene Therapy, Accelerating Clinical Trials & More
- Accelerating the Clinical Trial Process in Duchenne
- Gene Transfer in the Spotlight
- Webinar Q&A: Gene Therapy Part 2 – Nationwide Children's Hospital
- PPMD Research Update: September 2017
- FDA Announces Approval of First Gene Therapy in the United States
Most Popular Blog Posts
- PPMD Announces Gene Therapy Forum
- Newly Published Data Validates Micro-Dystrophin Gene Therapy Approach in Animal Model for Duchenne
- Duchenne Research Update: October 2016
- Duchenne Research Update: February 2017
- Accelerating the Clinical Trial Process in Duchenne
- Understanding Gene Therapy & CRISPR/Cas9
- Update on Gene Replacement/Repair Strategies for Duchenne Muscular Dystrophy
© 2022 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
